» Articles » PMID: 24432020

Therapeutic Implications of Immunogenic Cell Death in Human Cancer

Overview
Journal Front Immunol
Date 2014 Jan 17
PMID 24432020
Citations 15
Authors
Affiliations
Soon will be listed here.
Abstract

Dendritic cells (DCs) are central to the adoptive immune response, and their function is regulated by diverse signals in a context-specific manner. Different DCs have been described in physiologic conditions, inflammation, and cancer, prompting a series of questions on how adoptive immune responses, or tolerance, develop against tumors. Increasing evidence suggests that tumor treatments induce a dramatic change on tumor-infiltrating lymphocytes and, in particular, on some DC subtypes. In this review, we summarize the latest evidence on the role of DCs in cancer and preliminary evidence on chemotherapy-associated antigens identified in human cancers.

Citing Articles

It's high-time to re-evaluate the value of induced-chemotherapy for reinforcing immunotherapy in colorectal cancer.

Yao S, Han Y, Yang M, Jin K, Lan H Front Immunol. 2023; 14:1241208.

PMID: 37920463 PMC: 10619163. DOI: 10.3389/fimmu.2023.1241208.


Non-Oncologic Applications of Nanomedicine-Based Phototherapy.

Yoo S, Oh G, Ahn J, Chung E Biomedicines. 2021; 9(2).

PMID: 33504015 PMC: 7911939. DOI: 10.3390/biomedicines9020113.


Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens.

Grimaldi A, Cammarata I, Martire C, Focaccetti C, Piconese S, Buccilli M Commun Biol. 2020; 3(1):85.

PMID: 32099064 PMC: 7042341. DOI: 10.1038/s42003-020-0811-x.


Trial watch: chemotherapy-induced immunogenic cell death in immuno-oncology.

Vanmeerbeek I, Sprooten J, De Ruysscher D, Tejpar S, Vandenberghe P, Fucikova J Oncoimmunology. 2020; 9(1):1703449.

PMID: 32002302 PMC: 6959434. DOI: 10.1080/2162402X.2019.1703449.


Targeting photodynamic and photothermal therapy to the endoplasmic reticulum enhances immunogenic cancer cell death.

Li W, Yang J, Luo L, Jiang M, Qin B, Yin H Nat Commun. 2019; 10(1):3349.

PMID: 31350406 PMC: 6659660. DOI: 10.1038/s41467-019-11269-8.


References
1.
Michaud M, Martins I, Sukkurwala A, Adjemian S, Ma Y, Pellegatti P . Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice. Science. 2011; 334(6062):1573-7. DOI: 10.1126/science.1208347. View

2.
Hammer G, Ma A . Molecular control of steady-state dendritic cell maturation and immune homeostasis. Annu Rev Immunol. 2013; 31:743-91. PMC: 4091962. DOI: 10.1146/annurev-immunol-020711-074929. View

3.
Spisek R, Charalambous A, Mazumder A, Vesole D, Jagannath S, Dhodapkar M . Bortezomib enhances dendritic cell (DC)-mediated induction of immunity to human myeloma via exposure of cell surface heat shock protein 90 on dying tumor cells: therapeutic implications. Blood. 2007; 109(11):4839-45. PMC: 1885516. DOI: 10.1182/blood-2006-10-054221. View

4.
Zelenay S, Reis e Sousa C . Adaptive immunity after cell death. Trends Immunol. 2013; 34(7):329-35. DOI: 10.1016/j.it.2013.03.005. View

5.
Bennett C, Clausen B . DC ablation in mice: promises, pitfalls, and challenges. Trends Immunol. 2007; 28(12):525-31. DOI: 10.1016/j.it.2007.08.011. View